MICROMORT - Our Story

MICROMORT is a newly established company specialising in the development and certification of new processes and technical solutions for sterilisation of equipment and products within the pharmaceutical and related industries.

MicroMort was founded by John McNeilly, who has over 30 years’ experience in chemical and processing engineering, with the last 20 in the biopharmaceutical industry. The company is supported by the Board, led by John as CEO, with Alan Kelly as Commercial Director and Karen O’Neill in Finance and Administration. The formation of the company provides a platform for the continued evolution and development of new sterilisation technology and processes, which are our core capabilities.

 


Development and certification of effective sterilisation processes have become a very important and highly skilled area of work, requiring a thorough understanding of both the practicalities and limitations of modern production and packaging processes, coupled with a thorough understanding of the science involved.

Based on our combined decades of experience in the biotechnology, pharmaceutical and manufacturing fields, Micromort has developed a revolutionary way to sterilise packaging at lower cost and with a significantly reduced cycle time than traditional sterilising methods.

The Micromort organisation has extensive experience working with specialist teams able to undertake the design and testing of new sterilisation processes, and can work with end-users to meet the complex regulatory challenges and requirements in complex manufacturing environments with confidence.

Meet The Team

John McNeilly, Managing Director

Alan Kelly, Commercial Director



Karen O'Neill, Finance and Administration

Lia McNeilly, IT


© Copyright MicroMort, Ltd 2021                                                                                                                                                     CRO 679749